- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06180811
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women: Addressing Social Needs and Improving Health Outcomes
The purpose of this study is to conduct a pilot randomized controlled trial of a food is medicine community health worker intervention called the Women's Health Delaware Food Farmacy compared to the usual standard of care among pregnant ChristianaCare patients at risk for adverse clinical outcomes. The pilot study has three specific aims:
Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed
Aim 2: To determine the prevalence of and change in social needs
Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care
Study Overview
Status
Intervention / Treatment
Detailed Description
This study is a pilot randomized controlled trial where eligible pregnant ChristianaCare patients will be identified weekly through an automated list, and patients who consent will be randomized to 1 of 2 arms (Women's Health Delaware Food Farmacy vs. usual standard of care). Participants randomized to the Women's Health Delaware Food Farmacy program arm will receive medically tailored groceries that are high in micronutrients critical for a healthy pregnancy. The food provided will be the equivalent of 10 meals per person in the household per week and will be delivered to participants weekly from enrollment to 4 weeks after giving birth. Participants will receive culinary equipment and training, recipes, and educational nutrition videos and will interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. Participants randomized to the usual standard of care arm will continue to receive their standard of care management.
All participants will complete a questionnaire with patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) at baseline and postpartum and a patient experience survey postpartum related to their experiences receiving prenatal care and giving birth at ChristianaCare. In addition, maternal and child health, healthcare utilization, and clinical event outcomes will be documented for all participants via electronic health records and assessed retrospectively. Quantitative indicators related to feasibility (i.e., acceptability, demand, and implementation) will be collected such as program satisfaction, program enrollment and retention, meals provided to participants and their household, food consumption, and interactions with assigned Community Health Worker.
Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed
H1. Primary outcomes. The investigators hypothesize that the Women's Health Delaware Food Farmacy will: (a) prove acceptable to participants, as measured by program satisfaction; (b) meet demand, as measured by project recruitment and retention, number of meals provided to participants and their household, and number of people providing food for; and (c) prove implementable, as measured by food consumption, number of Community Health Worker interactions, number of educational videos watched, number of recipes reviewed, and number of meal preparation sessions.
Aim 2: To determine the prevalence of and change in social needs
H2. Primary outcome. Social needs will be identified by administering the ChristianaCare Social Determinants of Health Screener and resource referrals will be sent on participants' behalf to support their social needs, both of which are the usual standard of care. The investigators hypothesize that social needs will be identified through the ChristianaCare Social Determinants of Health Screener, and that compared to baseline, participants at postpartum will experience reductions in their social needs. The investigators also hypothesize there will be some participants whose social needs will not be resolved due to a lack of community resources.
Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care
H3a. Primary outcomes. Maternal and child health outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in maternal and child health outcomes (e.g., preeclampsia and small for gestational age) from baseline to postpartum.
H3b. Primary outcomes. Maternal and child healthcare utilization outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child healthcare utilization outcomes (e.g., neonatal intensive care unit [NICU] admission and maternal length of stay) from baseline to postpartum.
H3c. Primary outcomes. Maternal and child clinical event outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child clinical event outcomes (e.g., cesarean delivery and fetal death) from baseline to postpartum.
H3d. Secondary outcomes. Patient-reported outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) from baseline to postpartum.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kathleen McCallops, PhD
- Phone Number: 3024286590
- Email: kathleen.mccallops@christianacare.org
Study Contact Backup
- Name: Michelle Axe, MS, CHES
- Phone Number: 3024286590
- Email: michelle.axe@christianacare.org
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19718
- Recruiting
- ChristianaCare Christiana Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ChristianaCare Women's Health patient
- 18 years or older
- 4 to 14 weeks pregnant
- Singleton pregnancy
- Medicaid
- BMI of 30 or higher
- Reside in New Castle County
Exclusion Criteria:
- Current diagnosis of type 1 or type 2 diabetes
- Multiple pregnancy
- Currently enrolled in another Community Health Worker program
- Not able to store and prepare meals
- Diagnosed with severe medical comorbidities that might interfere with their ability to participate in the intervention, such as severe psychiatric illness or imminent hospitalization
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Women's Health Delaware Food Farmacy
Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly.
They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.
|
Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly.
They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.
|
Active Comparator: Usual Standard of Care
Participants will receive the usual standard of care.
|
Participants will receive the usual standard of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Determinants of Health
Time Frame: Changes from baseline to 2-6 weeks after delivery
|
Measured with ChristianaCare Social Determinants of Health Screener; Number of socials needs range from 0-11, higher scores indicate greater number of social needs
|
Changes from baseline to 2-6 weeks after delivery
|
Gestational Weight Gain
Time Frame: Changes from baseline to 2-6 weeks after delivery
|
Observed gestational weight gained
|
Changes from baseline to 2-6 weeks after delivery
|
Body Mass Index
Time Frame: Changes from baseline to 2-6 weeks after delivery
|
Observed body mass index changes
|
Changes from baseline to 2-6 weeks after delivery
|
Gestational Diabetes
Time Frame: From baseline to delivery
|
Occurrence of gestational diabetes
|
From baseline to delivery
|
Gestational Hypertension
Time Frame: From baseline to delivery
|
Occurrence of gestational hypertension
|
From baseline to delivery
|
Systolic and Diastolic Blood Pressure
Time Frame: Changes from baseline to 2-6 weeks after delivery
|
Observed systolic and diastolic blood pressure
|
Changes from baseline to 2-6 weeks after delivery
|
Preeclampsia
Time Frame: From baseline to 2-6 weeks after delivery
|
Occurrence of preeclampsia and week diagnosed during pregnancy
|
From baseline to 2-6 weeks after delivery
|
Hydramnios
Time Frame: From baseline to delivery
|
Occurrence of hydramnios
|
From baseline to delivery
|
Gestational Age
Time Frame: At delivery
|
Baby's gestational age at birth
|
At delivery
|
Small for Gestational Age
Time Frame: At delivery
|
Birth weight less than 10th percentile based on gestational age
|
At delivery
|
Preterm Birth
Time Frame: At delivery
|
Preterm birth less than 37 weeks
|
At delivery
|
Fetal Macrosomia
Time Frame: At delivery
|
Birth weight greater than 90th percentile based on gestational age
|
At delivery
|
Cesarean Delivery
Time Frame: At delivery
|
Occurrence of cesarean delivery including those planned and unplanned
|
At delivery
|
Fetal Death
Time Frame: From baseline to delivery
|
Occurrence of fetal death
|
From baseline to delivery
|
NICU Admission
Time Frame: Within 48 hours after delivery
|
Occurrence of NICU admission for any reason
|
Within 48 hours after delivery
|
NICU Length of Stay
Time Frame: From NICU admission date to NICU discharge date, assessed up to 90 days
|
Number of days baby was admitted to NICU
|
From NICU admission date to NICU discharge date, assessed up to 90 days
|
Maternal Length of Stay
Time Frame: From delivery date to hospital discharge date, assessed up to 90 days
|
Number of days hospitalized following delivery
|
From delivery date to hospital discharge date, assessed up to 90 days
|
Postpartum Admission
Time Frame: From delivery discharge to 90 days after
|
Number of postpartum hospital admissions for any reason
|
From delivery discharge to 90 days after
|
Postpartum Admission Length of Stay
Time Frame: From postpartum admission date to hospital discharge date, assessed up to 90 days
|
Number of days hospitalized
|
From postpartum admission date to hospital discharge date, assessed up to 90 days
|
Hospital Admission
Time Frame: From baseline up to delivery
|
Number of hospital admissions for any reason
|
From baseline up to delivery
|
Hospital Admission Length of Stay
Time Frame: From admission date to hospital discharge date, assessed up to 90 days
|
Number of days hospitalized
|
From admission date to hospital discharge date, assessed up to 90 days
|
Emergency Room Visit
Time Frame: From baseline to 90 days after delivery
|
Number of emergency room visits for any reason
|
From baseline to 90 days after delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Food Insecurity
Time Frame: Changes from baseline to 2-6 weeks after delivery
|
Measured with United States Department of Agriculture Household Food Security Survey Module 6-Item Short Form, 30-day; Scores range from 0-6, higher scores indicate lower food security
|
Changes from baseline to 2-6 weeks after delivery
|
Dietary Intake
Time Frame: Changes from baseline to 2-6 weeks after delivery
|
Measured with Dietary Screener Questionnaire (DSQ-10) and six items from Dietary Screener Questionnaire (DSQ-26); Scores will be calculated using the National Cancer Institute's scoring algorithms
|
Changes from baseline to 2-6 weeks after delivery
|
Health-Related Quality of Life
Time Frame: Changes from baseline to 2-6 weeks after delivery
|
Measured with Centers for Disease Control and Prevention's Health-Related Quality of Life (HRQOL-4) scale; Number of healthy days range from 0-30, higher scores indicate greater number of healthy days
|
Changes from baseline to 2-6 weeks after delivery
|
Cost-Related Medication Underuse
Time Frame: Changes from baseline to 2-6 weeks after delivery
|
Measured with Cost-Related Medication Underuse; Scores range from 0-4, scores greater than 0 indicate cost-related medication underuse
|
Changes from baseline to 2-6 weeks after delivery
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Glucose Metabolism Disorders
- Metabolic Diseases
- Endocrine System Diseases
- Diabetes Mellitus
- Pregnancy Complications
- Hypertension
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Eclampsia
- Pre-Eclampsia
- Diabetes, Gestational
- Hypertension, Pregnancy-Induced
Other Study ID Numbers
- 605512
- 90XP0484 (Other Grant/Funding Number: Administration for Children and Families)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Women's Health Delaware Food Farmacy
-
Ohio State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingDiabetes Mellitus, Type 2 | Nutrition Poor | Food DeprivationUnited States
-
John B Bulger, DOMassachusetts Institute of Technology; Stanford University; Geisinger Clinic; Cornell...Active, not recruiting
-
Centers for Disease Control and PreventionCompleted
-
Centers for Disease Control and PreventionUnknownCardiovascular Diseases | Chronic Diseases
-
Oregon Center for Applied Science, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedReproductive HealthUnited States
-
Wayne State UniversityBlue Cross Blue Shield of Michigan FoundationCompleted
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedObesity | Weight Gain | Women's HealthUnited States